Truvestments Capital LLC lifted its holdings in Cardinal Health Inc (NYSE:CAH) by 19.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 24,050 shares of the company’s stock after buying an additional 3,997 shares during the quarter. Truvestments Capital LLC’s holdings in Cardinal Health were worth $1,135,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Advantage Investment Management LLC bought a new stake in Cardinal Health in the 3rd quarter valued at about $31,000. Financial Gravity Wealth Inc. lifted its position in Cardinal Health by 258.5% in the 2nd quarter. Financial Gravity Wealth Inc. now owns 692 shares of the company’s stock valued at $33,000 after purchasing an additional 499 shares during the last quarter. SRS Capital Advisors Inc. bought a new stake in Cardinal Health in the 2nd quarter valued at about $36,000. Trustcore Financial Services LLC lifted its position in Cardinal Health by 80.6% in the 2nd quarter. Trustcore Financial Services LLC now owns 784 shares of the company’s stock valued at $37,000 after purchasing an additional 350 shares during the last quarter. Finally, AGF Investments LLC bought a new stake in Cardinal Health in the 2nd quarter valued at about $38,000. Institutional investors own 90.20% of the company’s stock.
CAH has been the topic of several recent research reports. Guggenheim set a $55.00 price objective on shares of Cardinal Health and gave the company a “buy” rating in a research report on Thursday, September 12th. Deutsche Bank initiated coverage on shares of Cardinal Health in a research report on Thursday, September 12th. They issued a “hold” rating and a $50.00 price objective on the stock. ValuEngine upgraded shares of Cardinal Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 2nd. Morgan Stanley cut their price objective on shares of Cardinal Health from $50.00 to $41.00 and set an “underweight” rating on the stock in a research report on Friday, September 6th. Finally, Argus downgraded shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, August 27th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. Cardinal Health currently has a consensus rating of “Hold” and an average price target of $53.63.
Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, August 8th. The company reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.18. Cardinal Health had a net margin of 0.94% and a return on equity of 25.96%. The company had revenue of $37.35 billion for the quarter, compared to the consensus estimate of $36.70 billion. During the same period in the previous year, the firm earned $1.01 EPS. Cardinal Health’s revenue was up 5.7% on a year-over-year basis. As a group, sell-side analysts predict that Cardinal Health Inc will post 4.99 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be given a dividend of $0.4811 per share. The ex-dividend date is Monday, September 30th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.18%. Cardinal Health’s dividend payout ratio (DPR) is 36.36%.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Featured Article: What are the most popular ETFs
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.